Sign Up Today and Learn More About Evommune Stock
Invest in or calculate the value of your shares in Evommune or other pre-IPO companies through EquityZen's platform.
Evommune Stock
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
About Evommune Stock
Founded
2020
Headquarters
Palo Alto, CA, US
Industries
Evommune Press Mentions
Stay in the know about the latest news on Evommune
Aprilbio, Evommune strike $475M deal for autoinflammatory drug
bioworld • Jun 25, 2024
Evommune Secures Exclusive Rights to Develop and Commercialize a Phase 2-ready IL-18 targeted fusion protein from AprilBio
prnewswire • Jun 25, 2024
Protein kinase c (pkc) theta inhibitor compounds
patents • Apr 14, 2024
Evommune Announces Expanded Strategic Collaboration with Maruho to Develop and Commercialize MRGPRX2 ...
prnewswire • Apr 09, 2024
Evommune and Accutar Collaborate on AI-based Drug Discovery
genengnews • Mar 01, 2024
Evommune Management
Leadership team at Evommune
Co-Founder & Chief Medical Officer
Eugene A. Bauer
Chief Corporate Strategy and Legal Officer
Greg Moss
Join now and verify your accreditation status to gain access to:
- Evommune current valuation
- Evommune stock price
- Available deals in Evommune and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Evommune stock?
Accredited investors can buy pre-IPO stock in companies like Evommune through EquityZen funds. These investments are made available by existing Evommune shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Evommune stock?
Shareholders can sell their Evommune stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
